Shedding a light on sex disparity in clinical trials in CKD patients.
chronic kidney disease
clinical studies
sex equity
Journal
Clinical kidney journal
ISSN: 2048-8505
Titre abrégé: Clin Kidney J
Pays: England
ID NLM: 101579321
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
12
04
2023
medline:
4
9
2023
pubmed:
4
9
2023
entrez:
4
9
2023
Statut:
epublish
Résumé
Clinical studies do not include an adequate proportion of female participants, and research data on drug efficacy and safety are generally collected from studies including a majority of men and extrapolated to women. This article describes the imbalance of male and female distribution in clinical studies, including patients with chronic kidney disease. The lack of sex equity in clinical research is a real 'public health problem' because not reporting sex-specific results may result in the loss of information on how a drug works according to sex. Therefore, it is essential to plan more research in the field of sex disparities in clinical studies to identify why women are underrepresented and to promote initiatives to expand women's participation in clinical studies.
Identifiants
pubmed: 37664573
doi: 10.1093/ckj/sfad163
pii: sfad163
pmc: PMC10468738
doi:
Types de publication
Editorial
Langues
eng
Pagination
1369-1371Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the ERA.
Déclaration de conflit d'intérêts
F.M. is member of the CKJ editorial board.
Références
Lancet. 1997 Mar 1;349(9052):588
pubmed: 9057728
Nat Rev Nephrol. 2018 Mar;14(3):151-164
pubmed: 29355169
N Engl J Med. 1993 Jul 22;329(4):292-6
pubmed: 8305004
J Clin Epidemiol. 2020 Jan;117:89-98
pubmed: 31589955
Haematologica. 2016 Jul;101(7):861-71
pubmed: 27056922
Euro Surveill. 2019 Sep;24(37):
pubmed: 31530345